The landscape for drug and device development is under tremendous transition and strain as companies grapple with economic and political pressure and uncertainty, as well as shifting regulatory dynamics. Widespread layoffs across biotech and pharma, coupled with staffing cuts at key regulatory agencies like the FDA, are slowing progress and increasing risk. At the same time, investor hesitancy and reduced federal funding for research institutions and universities is constraining early-stage innovation. In this environment, companies must operate with heightened strategic clarity, flexibility, and consistency to advance their programs and products efficiently, while navigating these operational and regulatory  

RegDev’s Regulatory Affairs team brings deep, cross-functional expertise to help you advance through development and regulatory milestones with confidence. Our seasoned consultants work across early and late-stage development in a wide array of therapeutic areas including oncology, rare diseases, pediatrics, diabetes, and infectious diseases. Our experience spans small and large molecules, peptides, biologics, parenterals, topicals, devices, and combination products.

We offer practical, patient-focused, fiscally responsible, and economically sustainable support that includes: 

🔍 Strategic Guidance

We craft fit-for-purpose regulatory strategies tailored to your goals, product type, and stage of development. Whether advising at an ad-hoc, team, or executive level, we help you navigate complex regulatory pathways while staying aligned with business objectives and return on investment. 

✍️ ️Tactical Regulatory Execution

Our consultants lead, strategically design, draft, or support (e.g., gap assessments) the development of regulatory health authority submissions including INDs, CTAs, NDAs, BLAs, 510(k)s, PMAs, and IDEs. We draft and refine briefing packages, responses to queries, designation requests, and regulatory meeting content—always with an eye toward clarity, compliance, and successful outcomes. 

🤝 Integrated, Collaborative Approach

RegDev is built on a culture of integrity and collaboration. Our team becomes an extension of yours, integrating seamlessly with internal personnel to provide both strategic insight and tactical execution. We consider ourselves your colleagues, united by a shared mission: bringing new and innovative therapies to patients in need. 

🧪 End-to-End Regulatory CMC Expertise

From tablets and capsules to injectables, topicals, and pre-filled syringes, we bring comprehensive Regulatory CMC experience. Our consultants support development across all phases—from preclinical through post-approval—and provide guidance grounded in real-world industry experience.

🤝Trusted Partnership

At the heart of every engagement is strong communication, empathy, and a clear understanding of your priorities. We don’t just advise—we collaborate. We work with you, not just for you. Whether you’re facing the challenges of rapid growth, shifting regulations, or evolving portfolio priorities, RegDev offers the steady, strategic, and expert support you need to keep moving forward.

Let’s work together to accelerate the delivery of life-changing therapies.

Get in touch to learn more about our Regulatory expertise and tailored solutions.